Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation
Molecules · 2024
DOI: 10.3390/molecules30010117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Alexander Popov und 11 weiteren Autor:innen. Beteiligte Einrichtung: M. V. Lomonosov Institute of Fine Chemical Technology, MIREA-Russian Technological University, 86 Vernadsky Av., 119571 Moscow, Russia. Hauptthemen laut MEDLINE: Porphyrins, Radiopharmaceuticals, Technetium, Nicotinic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIREA - Russian Technological University, RTU MIREA.
Abstract (Originalsprache)
The use of radiopharmaceuticals for diagnostics in oncology allows for the detection of the disease at an early stage. Among diagnostic radionuclides, 99mTc is a promising isotope that has been used to create several drugs for clinical use. One of the most effective 99mTc chelators is 6-hydrazinylnicotinic acid (HYNIC), which, when combined with various vector molecules, can be used for targeted delivery of radionuclides to tumor tissues. At the same time, it is known that tetrapyrrole macrocycles are capable of selective accumulation in tumors, and thus can be used to target radiopharmaceuticals with 99mTc. In this work, the conjugate of natural chlorin and HYNIC was obtained, and preliminary preclinical studies were carried out on its radiocomplex with 99mTc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- M. V. Lomonosov Institute of Fine Chemical Technology, MIREA-Russian Technological University, 86 Vernadsky Av., 119571 Moscow, Russia.
- Science and Education Laboratory for Chemical and Pharmaceutical Research, Siberian State Medical University, 634050 Tomsk, Russia.
- Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, Tomsk Polytechnic University, 634050 Tomsk, Russia.
- P. A. Hertsen Moscow Oncology Research Center, 125284 Moscow, Russia.
- Department of Pharmaceutical Analysis, Siberian State Medical University, 634050 Tomsk, Russia.
ORCID-Profile: Alexander Popov, Nikita Suvorov, Mariia Larkina, Evgenii Plotnikov, Petr Ostroverkhov, Mikhail Belousov
Förderung
- MIREA - Russian Technological University
- RTU MIREA
Zitieren
APA
Popov, A., Suvorov, N., Larkina, M., Plotnikov, E., Varvashenya, R., Bodenko, V., Yanovich, G., Ostroverkhov, P., Usachev, M., Filonenko, E., Belousov, M., & Grin, M. (2024). Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation. Molecules. https://doi.org/10.3390/molecules30010117
Vancouver
Popov A, Suvorov N, Larkina M, Plotnikov E, Varvashenya R, Bodenko V, et al. Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation. Molecules. 2024. doi:10.3390/molecules30010117
BibTeX
@article{Popov2024,
author = {Popov, Alexander and Suvorov, Nikita and Larkina, Mariia and Plotnikov, Evgenii and Varvashenya, Ruslan and Bodenko, Vitalina and Yanovich, Gleb and Ostroverkhov, Petr and Usachev, Maxim and Filonenko, Elena and Belousov, Mikhail and Grin, Mikhail},
title = {Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules30010117}
}
EUVIMED